Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ascendis Pharma
Ascendis Pharma
(ASND)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Skytrofa
Lonapegsomatropin
2021-08-25
Growth and development
Skytrofa (previously lonapegsomatropin ascendis pharma)
Lonapegsomatropin
2022-01-11
Growth and development
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lonapegsomatropin
healthy volunteers/patients
,
laron syndrome
,
pituitary dwarfism
,
endocrine system diseases
,
failure to thrive
,
turner syndrome
,
pituitary diseases
,
sex chromosome disorders
,
chromosome disorders
,
noonan syndrome
,
dwarfism
,
sex chromosome disorders of sex development
Palopegteriparatide
hypoparathyroidism
,
endocrine system diseases
,
parathyroid diseases
,
calcium metabolism disorders
Gilvetmab
colorectal neoplasms
,
squamous cell neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
neoplasm metastasis
,
sarcoma
,
squamous cell carcinoma
,
merkel cell carcinoma
,
endometrial neoplasms
,
hepatocellular carcinoma
,
transitional cell carcinoma
,
head and neck neoplasms
,
pancreatic ductal carcinoma
,
colonic neoplasms
,
rectal neoplasms
,
triple negative breast neoplasms
,
mycoses
,
mycosis fungoides
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
uterine cervical neoplasms
,
small cell lung carcinoma
,
pancreatic neoplasms
,
bile duct neoplasms
,
liver neoplasms
,
rectal diseases
,
melanoma
,
neoplasms
,
renal cell carcinoma
,
ovarian neoplasms
,
urologic neoplasms
,
carcinoma
,
lung neoplasms
,
breast neoplasms
,
ovarian epithelial carcinoma
,
adenocarcinoma
,
urologic diseases
,
kidney neoplasms
,
fallopian tube neoplasms
,
peritoneal neoplasms
,
urinary bladder diseases
,
neoadjuvant therapy
,
skin neoplasms
,
kidney diseases
,
urogenital neoplasms
,
neoplasms by site
,
glandular and epithelial neoplasms
,
non-small-cell lung carcinoma
,
squamous cell carcinoma of head and neck
,
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
Aspartame
beta-thalassemia
,
thalassemia
,
iron overload
,
newborn respiratory distress syndrome
,
asthma
Bevifimod
hypersensitivity
,
delayed hypersensitivity
Nadide
colorectal neoplasms
Endocrine
type 2 diabetes mellitus
,
diabetes mellitus
,
neoplasms
,
type 1 diabetes mellitus
,
palliative care
,
cardiometabolic risk factors
,
diet therapy
,
gestational diabetes
,
heart failure
Mk3475
squamous cell carcinoma of head and neck
,
melanoma
,
recurrence
,
triple negative breast neoplasms
,
renal cell carcinoma
,
neoplasms
,
non-hodgkin lymphoma
,
multiple myeloma
,
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
colorectal neoplasms
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
lung neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use